NURS 5354: Exam 3 woman's health
ANSWER KEY 2025/ 2026
•Consider:
•Effectiveness
when selecting a birth control •Safety
method, consider: •Personal preference!
•Mechanism: Inhibition of ovulation
•Classification (two main categories)
•Combination oral contraceptives (OCs)
oral contraceptives •Estrogen and Progestin
•Progestin-only OCs ("mini-pills")
Estrogen
•Ethinyl estradiol
•Mestranol
Components of OCPs •Estradiol valerate
Progestin
effectiveness:
•Failure rate - 0.3% to 8% depending on if using perfectly
combonation OCs •Increased BMI affects efficacy as well
Thromboembolic disorders
Hypertension
Cancer
Stroke in patients with migraine
Teratogenic effects
Combination OCs: Adverse Abnormal uterine bleeding
Effects Use in pregnancy and lactation
Benign hepatic adenoma
•Thrombophlebitis, thromboembolic disorder
•CV disease, coronary occlusion
•Abnormal liver function
•Breast cancer
Contraindications: Absolute – •Undiagnosed vaginal bleeding
Never prescribe if History of •Pregnancy
these
•Smokers
•Hypertension, cardiac disease
•Diabetes
•Gallbladder disease, history of cholestatic
•Jaundice of pregnancy
contraindications: Relative – Can
•Uterine leiomyoma
prescribe in some •Epilepsy
circumstances Migraines
•Decreased Risks of ovarian & endometrial cancer, ovarian cysts,
Noncontraceptive Benefits of
OCs PID, benign breast disease, iron deficiency anemia, and acne
ANSWER KEY 2025/ 2026
•Consider:
•Effectiveness
when selecting a birth control •Safety
method, consider: •Personal preference!
•Mechanism: Inhibition of ovulation
•Classification (two main categories)
•Combination oral contraceptives (OCs)
oral contraceptives •Estrogen and Progestin
•Progestin-only OCs ("mini-pills")
Estrogen
•Ethinyl estradiol
•Mestranol
Components of OCPs •Estradiol valerate
Progestin
effectiveness:
•Failure rate - 0.3% to 8% depending on if using perfectly
combonation OCs •Increased BMI affects efficacy as well
Thromboembolic disorders
Hypertension
Cancer
Stroke in patients with migraine
Teratogenic effects
Combination OCs: Adverse Abnormal uterine bleeding
Effects Use in pregnancy and lactation
Benign hepatic adenoma
•Thrombophlebitis, thromboembolic disorder
•CV disease, coronary occlusion
•Abnormal liver function
•Breast cancer
Contraindications: Absolute – •Undiagnosed vaginal bleeding
Never prescribe if History of •Pregnancy
these
•Smokers
•Hypertension, cardiac disease
•Diabetes
•Gallbladder disease, history of cholestatic
•Jaundice of pregnancy
contraindications: Relative – Can
•Uterine leiomyoma
prescribe in some •Epilepsy
circumstances Migraines
•Decreased Risks of ovarian & endometrial cancer, ovarian cysts,
Noncontraceptive Benefits of
OCs PID, benign breast disease, iron deficiency anemia, and acne
